Inventor · disambiguated record
Thomas Pillow
Also filed as: PILLOW THOMAS · PILLOW THOMAS H · PILLOW THOMAS HARDEN
42 granted patents·17 pending applications·97 citations·filing 2011–2024
97Inventor score
Top patents by PatentIndex Score
59 records- 0196US9518118B2Anti-HER2 antibodies and immunoconjugatesGENENTECH INC·Filed 2015·Granted Dec 13, 2016·22 cites·29 claims
- 0294US11242344B2(4-hydroxypyrrolidin-2-yl)-heterocyclic compounds and methods of use thereofGENENTECH INC·Filed 2020·Granted Feb 8, 2022·5 cites·29 claims
- 0393US10017577B2Antibodies and immunoconjugatesGENENTECH INC·Filed 2016·Granted Jul 10, 2018·9 cites·38 claims
- 0492US9649390B2Pyrrolobenzodiazepines and conjugates thereofMEDIMMUNE LTD·Filed 2014·Granted May 16, 2017·19 cites·13 claims
- 0590US10179820B2Anti-HER2 antibodies and immunoconjugatesGENENTECH INC·Filed 2016·Granted Jan 15, 2019·6 cites·26 claims
- 0686US9803002B2Anti-wall teichoic antibodies and conjugatesGENENTECH INC·Filed 2014·Granted Oct 31, 2017·6 cites·58 claims
- 0785US10639373B2Pyrrolobenzodiazepine antibody drug conjugates and methods of useGENENTECH INC·Filed 2018·Granted May 5, 2020·2 cites·48 claims
- 0884US12440706B2Conjugated chemical inducers of degradation and methods of useGENENTECH INC·Filed 2021·Granted Oct 14, 2025·1 cites·17 claims
- 0983US10556966B2Anti-HER2 antibodies and immunoconjugatesGENENTECH INC·Filed 2018·Granted Feb 11, 2020·2 cites·44 claims
- 1083US10533058B2Peptidomimetic compounds and antibody-drug conjugates thereofGENENTECH INC·Filed 2014·Granted Jan 14, 2020·2 cites·7 claims
- 1182US12492263B2Anti-HER2 antibodies and immunoconjugatesGENENTECH INC·Filed 2022·Granted Dec 9, 2025·0 cites·15 claims
- 1281US10639378B2Silvestrol antibody-drug conjugates and methods of useGENENTECH INC·Filed 2017·Granted May 5, 2020·1 cites·7 claims
- 1381US10124069B2Peptidomimetic compounds and antibody-drug conjugates thereofGENENTECH INC·Filed 2016·Granted Nov 13, 2018·3 cites·26 claims
- 1481US10077318B2Cysteine engineered antibodies and conjugatesGENENTECH INC·Filed 2015·Granted Sep 18, 2018·5 cites·41 claims
- 1580US10058613B2Pyrrolobenzodiazepine antibody drug conjugates and methods of useGENENTECH INC·Filed 2016·Granted Aug 28, 2018·2 cites·10 claims
- 1679US11666581B2PROTAC antibody conjugates and methods of useGENENTECH INC·Filed 2018·Granted Jun 6, 2023·2 cites·22 claims
- 1779US10314846B2Immunoconjugates comprising anti-HER2 antibodies and pyrrolobenzodiazepinesGENENTECH INC·Filed 2017·Granted Jun 11, 2019·2 cites·64 claims
- 1877US9821074B2Pyrrolobenzodiazepines and conjugates thereofSPIROGEN SÀRL·Filed 2014·Granted Nov 21, 2017·3 cites·8 claims
- 1976US11547762B2Methods for preparing antibody drug conjugatesGENENTECH INC·Filed 2019·Granted Jan 10, 2023·1 cites·10 claims
- 2076US11135303B2Pyrrolobenzodiazepines and conjugates thereofMEDIMMUNE LTD·Filed 2012·Granted Oct 5, 2021·1 cites·36 claims
- 2175US11104673B2Quaternary amine compounds and antibody-drug conjugates thereofGENENTECH INC·Filed 2019·Granted Aug 31, 2021·0 cites·18 claims
- 2275US2020255539A1Anti-HER2 Antibodies and ImmunoconjugatesGENENTECH INC·Filed 2019·Application pending·0 cites
- 2374US2025084096A1Tert-butyl (s)-2-(4-(phenyl)-6h-thieno[3, 2-f][1, 2, 4]triazolo[4, 3-a] [1,4]diazepin-6-yl) acetate derivatives and related compounds as bromodomain brd4 inhibitors for treating cancerGENENTECH INC·Filed 2024·Application pending·0 cites
- 2473US12090211B2Methods for preparing antibody drug conjugatesGENENTECH INC·Filed 2022·Granted Sep 17, 2024·0 cites·13 claims
- 2571US10149913B2Anthracycline disulfide intermediates, antibody-drug conjugates and methodsGENENTECH INC·Filed 2015·Granted Dec 11, 2018·1 cites·20 claims
- 2671US9884126B2Anti-wall teichoic antibodies and conjugatesGENENTECH INC·Filed 2014·Granted Feb 6, 2018·1 cites·26 claims
- 2769US11576979B2Pyrrolobenzodiazepine prodrugs and antibody conjugates thereofGENENTECH INC·Filed 2019·Granted Feb 14, 2023·0 cites·10 claims
- 2869US9999681B2Peptidomimetic compounds and antibody-drug conjugates thereofGENENTECH INC·Filed 2016·Granted Jun 19, 2018·1 cites·30 claims
- 2969US2023330102A1Protac antibody conjugates and methods of useGENENTECH INC·Filed 2023·Application pending·0 cites
- 3068US11090322B2Anthracycline disulfide intermediates, antibody-drug conjugates and methodsGENENTECH INC·Filed 2018·Granted Aug 17, 2021·0 cites·15 claims
- 3167US10730900B2Calicheamicin-antibody-drug conjugates and methods of useGENENTECH INC·Filed 2019·Granted Aug 4, 2020·0 cites·23 claims
- 3266US2023130874A1Cysteine Engineered Antibodies and ConjugatesGENENTECH INC·Filed 2022·Application pending·0 cites
- 3365US2025122280A1ANTI-Ly6E ANTIBODIES, IMMUNOCONJUGATES, AND USES THEREOFGENENTECH INC·Filed 2024·Application pending·0 cites
- 3464US10632196B2Pyrrolobenzodiazepine antibody drug conjugates and methods of useGENENTECH INC·Filed 2018·Granted Apr 28, 2020·0 cites·58 claims
- 3563US12152040B2Tert-butyl (s)-2-(4-(phenyl)-6H-thieno[3, 2-f][1, 2, 4]triazolo[4, 3-a] [1,4]diazepin-6-yl) acetate derivatives and related compounds as bromodomain BRD4 inhibitors for treating cancerGENENTECH INC·Filed 2021·Granted Nov 26, 2024·0 cites·31 claims
- 3663US11692043B2Peptidomimetic compounds and antibody-drug conjugates thereofGENENTECH INC·Filed 2019·Granted Jul 4, 2023·0 cites·6 claims
- 3761US11648315B2Silvestrol antibody-drug conjugates and methods of useGENENTECH INC·Filed 2020·Granted May 16, 2023·0 cites·24 claims
- 3861US2023330249A1Antibody-conjugated chemical inducers of degradation of brm and methods thereofGENENTECH INC·Filed 2023·Application pending·0 cites
- 3959US10576164B2Pyrrolobenzodiazepines and conjugates thereofMEDIMMUNE LTD·Filed 2017·Granted Mar 3, 2020·0 cites·1 claims
- 4058US10632210B2Peptidomimetic compounds and antibody-drug conjugates thereofGENENTECH INC·Filed 2018·Granted Apr 28, 2020·0 cites·7 claims
- 4157US10570192B2Anti-wall teichoic antibodies and conjugatesGENENTECH INC·Filed 2017·Granted Feb 25, 2020·0 cites·11 claims
- 4257US10556895B2Quaternary amine compounds and antibody-drug conjugates thereofGENENTECH INC·Filed 2017·Granted Feb 11, 2020·0 cites·6 claims
- 4354US10370399B2Calicheamicin-antibody-drug conjugates and methods of useGENENTECH INC·Filed 2016·Granted Aug 6, 2019·0 cites·6 claims
- 4453US2018085470A1Anti-wall teichoic antibodies and conjugatesGENENTECH INC·Filed 2017·Application pending·0 cites
- 4553US2020085840A1Immunoconjugates Comprising Anti-HER2 Antibodies and PyrrolobenzodiazepinesGENENTECH INC·Filed 2019·Application pending·0 cites
- 4652US10532108B2Pyrrolobenzodiazepine prodrugs and antibody conjugates thereofGENENTECH INC·Filed 2019·Granted Jan 14, 2020·0 cites·29 claims
- 4752US2014356375A1Anti-wall teichoic antibodies and conjugatesGENENTECH INC·Filed 2014·Application pending·0 cites
- 4852US2020017601A1Cysteine engineered antibodies and conjugatesGENENTECH INC·Filed 2019·Application pending·0 cites
- 4951US9895450B2Anti-wall teichoic antibodies and conjugatesGENENTECH INC·Filed 2015·Granted Feb 20, 2018·0 cites·23 claims
- 5051US2014030279A1Anti-cd22 antibodies and immunoconjugatesSpirogen Sari·Filed 2013·Application pending·0 cites
Showing the top 50 of 59 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →